Debate Heats Up On GM Foods

Genetically modified (GM) crops, and foods derived from them, continue to ignite controversy and spur jockeying by trade groups and businesses. At its January convention in Houston, the American Farm Bureau Federation, which represents the interests of farmers, released results of a survey last summer on attitudes toward biotechnology and food. Biotechnology was supported by 57 percent of the 1,002 respondents if it improved taste, 65 percent if it improved nutritional value, 69 percent if it in

Written byDouglas Steinberg
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Genetically modified (GM) crops, and foods derived from them, continue to ignite controversy and spur jockeying by trade groups and businesses. At its January convention in Houston, the American Farm Bureau Federation, which represents the interests of farmers, released results of a survey last summer on attitudes toward biotechnology and food. Biotechnology was supported by 57 percent of the 1,002 respondents if it improved taste, 65 percent if it improved nutritional value, 69 percent if it increased food production, and 73 percent if it reduced pesticide use.1

Some companies, however, appear to be getting a different message. Last month, the two largest natural-food chains in the United States, Wild Oats Markets and Whole Foods Market, indicated that their house brands would soon be free of GM materials. This development follows similar moves by Gerber Products Co. and H.J. Heinz Co.

The contentiousness surrounding GM food enlivened a symposium on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies